Preparation and evaluation of modified composition for lyophilized kits of [Cu(MIBI)4]BF4 for [99mTc] technetium labeling

The [Cu(MIBI)4]BF4 complex was synthesized and different formulations for lyophilized kits that could be cost-effectively used with different routines in nuclear medicine laboratories were investigated. In one preparation the kit components were kept similar to the Cardiolite® , except that the SnCl...

Full description

Bibliographic Details
Main Authors: Marisa de Jesus de C. Lima, Fabio Luiz Navarro Marques, Miriam Roseli Yoshie Okamoto, Alexandre Tales Garcez, Marcelo Tatit Sapienza, Carlos Alberto Buchpiguel
Format: Article
Language:English
Published: Instituto de Tecnologia do Paraná (Tecpar) 2005-10-01
Series:Brazilian Archives of Biology and Technology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132005000700001
id doaj-3a396de396e34faaacaa847494b83772
record_format Article
spelling doaj-3a396de396e34faaacaa847494b837722020-11-25T00:34:32ZengInstituto de Tecnologia do Paraná (Tecpar)Brazilian Archives of Biology and Technology1516-89131678-43242005-10-0148spe21810.1590/S1516-89132005000700001Preparation and evaluation of modified composition for lyophilized kits of [Cu(MIBI)4]BF4 for [99mTc] technetium labelingMarisa de Jesus de C. LimaFabio Luiz Navarro MarquesMiriam Roseli Yoshie OkamotoAlexandre Tales GarcezMarcelo Tatit SapienzaCarlos Alberto BuchpiguelThe [Cu(MIBI)4]BF4 complex was synthesized and different formulations for lyophilized kits that could be cost-effectively used with different routines in nuclear medicine laboratories were investigated. In one preparation the kit components were kept similar to the Cardiolite® , except that the SnCl2.2H2O concentration was increased to 0.150 mg. In a second formulation, component concentrations were reduced to 1/5 of the original value and the SnCl2.2H2O concentration was adjusted to 0.04 mg. These products were labeled with maximum activities of 55.5 GBq and 8.14 GBq, respectively, and have shown an average radiochemical purity of 95 %. Biodistribution of the products was assessed by dissection in mice and in rabbits, and did not show any statistical difference when compared to Cardiolite®. In the synthesis of [Cu(MIBI)4]BF4 a new procedure was introduced for the synthesis of N-(2-methyl-propenyl)-formamide, with the use of microwave radiation as heat source. This modification reduced the reaction time to 25 seconds, while maintaining a yield of 68%.<br>Neste trabalho são apresentados dados relativos a síntese do complexo [Cu(MIBI)4]BF4 e à utilização do mesmo para produção de kit liofilizado para obtenção do radiofármaco [[99mTc](MIBI)6]+. No processo de síntese foi utilizado radiação de microondas como fonte de aquecimento em uma etapa do processo, permitindo que a reação fosse executada em 25 segundos, obtendo rendimento de 68 %. Na preparação dos kits liofilizados, um deles denominado FULL, nos quais a quantidade dos componentes foi mantida igual ao produto comercial Cardiolite®, e outro denominado FRACTION, nos quais as quantidades foram reduzidas a 1/5 do total, foram adicionadas quantidades extras de SnCl2.2H2O. Deste modo, tornou-se possível marcar os kits liofilizados com atividades máximas de 55,5 GBq e 8,14 GBq, respectivamente. A biodistribuição dos produtos marcados, em camundongos e coelhos, não mostrou diferença estatística (p>0,05), para o teste t de Student, quando comparada ao produto obtido pela reconstituição do Cardiolite®.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132005000700001[99mTc]technetium[[99mTc](MIBI)6]+radiopharmaceuticalbiodistribution
collection DOAJ
language English
format Article
sources DOAJ
author Marisa de Jesus de C. Lima
Fabio Luiz Navarro Marques
Miriam Roseli Yoshie Okamoto
Alexandre Tales Garcez
Marcelo Tatit Sapienza
Carlos Alberto Buchpiguel
spellingShingle Marisa de Jesus de C. Lima
Fabio Luiz Navarro Marques
Miriam Roseli Yoshie Okamoto
Alexandre Tales Garcez
Marcelo Tatit Sapienza
Carlos Alberto Buchpiguel
Preparation and evaluation of modified composition for lyophilized kits of [Cu(MIBI)4]BF4 for [99mTc] technetium labeling
Brazilian Archives of Biology and Technology
[99mTc]technetium
[[99mTc](MIBI)6]+
radiopharmaceutical
biodistribution
author_facet Marisa de Jesus de C. Lima
Fabio Luiz Navarro Marques
Miriam Roseli Yoshie Okamoto
Alexandre Tales Garcez
Marcelo Tatit Sapienza
Carlos Alberto Buchpiguel
author_sort Marisa de Jesus de C. Lima
title Preparation and evaluation of modified composition for lyophilized kits of [Cu(MIBI)4]BF4 for [99mTc] technetium labeling
title_short Preparation and evaluation of modified composition for lyophilized kits of [Cu(MIBI)4]BF4 for [99mTc] technetium labeling
title_full Preparation and evaluation of modified composition for lyophilized kits of [Cu(MIBI)4]BF4 for [99mTc] technetium labeling
title_fullStr Preparation and evaluation of modified composition for lyophilized kits of [Cu(MIBI)4]BF4 for [99mTc] technetium labeling
title_full_unstemmed Preparation and evaluation of modified composition for lyophilized kits of [Cu(MIBI)4]BF4 for [99mTc] technetium labeling
title_sort preparation and evaluation of modified composition for lyophilized kits of [cu(mibi)4]bf4 for [99mtc] technetium labeling
publisher Instituto de Tecnologia do Paraná (Tecpar)
series Brazilian Archives of Biology and Technology
issn 1516-8913
1678-4324
publishDate 2005-10-01
description The [Cu(MIBI)4]BF4 complex was synthesized and different formulations for lyophilized kits that could be cost-effectively used with different routines in nuclear medicine laboratories were investigated. In one preparation the kit components were kept similar to the Cardiolite® , except that the SnCl2.2H2O concentration was increased to 0.150 mg. In a second formulation, component concentrations were reduced to 1/5 of the original value and the SnCl2.2H2O concentration was adjusted to 0.04 mg. These products were labeled with maximum activities of 55.5 GBq and 8.14 GBq, respectively, and have shown an average radiochemical purity of 95 %. Biodistribution of the products was assessed by dissection in mice and in rabbits, and did not show any statistical difference when compared to Cardiolite®. In the synthesis of [Cu(MIBI)4]BF4 a new procedure was introduced for the synthesis of N-(2-methyl-propenyl)-formamide, with the use of microwave radiation as heat source. This modification reduced the reaction time to 25 seconds, while maintaining a yield of 68%.<br>Neste trabalho são apresentados dados relativos a síntese do complexo [Cu(MIBI)4]BF4 e à utilização do mesmo para produção de kit liofilizado para obtenção do radiofármaco [[99mTc](MIBI)6]+. No processo de síntese foi utilizado radiação de microondas como fonte de aquecimento em uma etapa do processo, permitindo que a reação fosse executada em 25 segundos, obtendo rendimento de 68 %. Na preparação dos kits liofilizados, um deles denominado FULL, nos quais a quantidade dos componentes foi mantida igual ao produto comercial Cardiolite®, e outro denominado FRACTION, nos quais as quantidades foram reduzidas a 1/5 do total, foram adicionadas quantidades extras de SnCl2.2H2O. Deste modo, tornou-se possível marcar os kits liofilizados com atividades máximas de 55,5 GBq e 8,14 GBq, respectivamente. A biodistribuição dos produtos marcados, em camundongos e coelhos, não mostrou diferença estatística (p>0,05), para o teste t de Student, quando comparada ao produto obtido pela reconstituição do Cardiolite®.
topic [99mTc]technetium
[[99mTc](MIBI)6]+
radiopharmaceutical
biodistribution
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132005000700001
work_keys_str_mv AT marisadejesusdeclima preparationandevaluationofmodifiedcompositionforlyophilizedkitsofcumibi4bf4for99mtctechnetiumlabeling
AT fabioluiznavarromarques preparationandevaluationofmodifiedcompositionforlyophilizedkitsofcumibi4bf4for99mtctechnetiumlabeling
AT miriamroseliyoshieokamoto preparationandevaluationofmodifiedcompositionforlyophilizedkitsofcumibi4bf4for99mtctechnetiumlabeling
AT alexandretalesgarcez preparationandevaluationofmodifiedcompositionforlyophilizedkitsofcumibi4bf4for99mtctechnetiumlabeling
AT marcelotatitsapienza preparationandevaluationofmodifiedcompositionforlyophilizedkitsofcumibi4bf4for99mtctechnetiumlabeling
AT carlosalbertobuchpiguel preparationandevaluationofmodifiedcompositionforlyophilizedkitsofcumibi4bf4for99mtctechnetiumlabeling
_version_ 1725312855093280768